Quick jump to page content
  • Main Navigation
  • Main Content
  • Sidebar
  • Register
  • Login
  • Home
  • Archives
  • Current
  • About
    • Aim & Scope
    • Editorial Team
    • Editorial board
    • Copyrights
    • Privacy Statement
  • Ethics
    • For authors
    • For editors
    • For reviewers
    • Special cases
  • For authors
    • Submissions
    • Authors guidelines
    • Review process
  • Reviewers
  • Contact us
  • Publisher
    • Medical Education
    • Medical Education Bookshop
    • Contact
  1. Home
  2. Archives
  3. Vol 20 No 4 (2024)

Published: 2025-05-25

THERAPY

Combination of azelastine/fluticasone in the guidelines, recommendations and everyday clinical practice in the management of allergic rhinitis

Review article

Maciej Kupczyk

3-8

PDF (Język Polski)

Safety of using the 300 IR tablet containing house dust mite allergens for sublingual immunotherapy

Review: Worm M, Demoly P, Okamoto Y et al. Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data.

Andrzej Bożek

9-12

PDF (Język Polski)

Sublingual immunotherapy with a 300 IR tablet containing pollen from 5 grasses. A targeted systematic review and meta-analysis confirm clinical benefits for patients with allergic rhinitis and conjunctivitis, with or without concomitant asthma

Review: Di Bona D, Paoletti G, Ordak M, Dragonieri S, Cognet-Sice J, Scurati S, Canonica GW. A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma

Iwona Poziomkowska-Gęsicka

13-18

PDF (Język Polski)

Allergen immunotherapy for the prevention and treatment of asthma

Review: Batard T, Taille C, Guilleminault L et al. Allergen Immunotherapy for the Prevention and Treatment of Asthma

Łukasz Błażowski

19-26

PDF (Język Polski)
Language
  • Język Polski
  • English
Make a Submission

AHEAD OF PRINT

About this Publishing System